Related Experiment Video

Updated: Nov 18, 2025

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K

[Cardiogenic shock : etiology and management]

R Dumont1, J Tridetti1, A Ancion1

  • 1Service de Cardiologie, CHU Liège, Belgique.

Revue Medicale De Liege
|February 5, 2021
PubMed

Insights

Cardiogenic shock, a severe circulatory issue often stemming from heart attacks, leads to organ damage and has a high mortality rate. Prompt treatment with coronary revascularization and supportive care is crucial for survival.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock is a life-threatening circulatory shock type characterized by organ hypoperfusion and potential multivisceral failure.
  • It carries a high mortality rate, approaching 50%, highlighting the critical nature of this condition.
  • While often secondary to acute myocardial infarction (80% of cases), it complicates only 5-10% of heart attacks, particularly in multi-vessel coronary artery disease.

Framework:

  • Understanding cardiogenic shock involves recognizing its distinct pathophysiology within the broader spectrum of circulatory shock.
  • Identifying risk factors, such as severe coronary artery disease, is key to early diagnosis and intervention.
  • The condition necessitates a multidisciplinary approach for effective management.

Implementation:

  • Primary treatment strategies focus on coronary revascularization to restore blood flow to the ischemic myocardium.
  • Supportive care is essential, encompassing hemodynamic stabilization and organ support.
  • Early recognition and timely intervention are critical for improving patient outcomes.

Implications:

  • Effective management of cardiogenic shock can significantly reduce mortality rates and improve long-term prognosis.
  • Advances in treatment strategies, including revascularization techniques and supportive therapies, are vital for patient survival.
  • Further research into predicting and preventing cardiogenic shock in high-risk populations is warranted.

Keywords:
Cardiogenic shockHeart TeamMyocardial infarctionIntensive care

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K
The Intra-Aortic Balloon Pump06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

23.1K

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
243
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
122
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
102
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
89